Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (Parentheticals)

v3.19.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (Parentheticals) - USD ($)
3 Months Ended 6 Months Ended
Apr. 30, 2019
Apr. 30, 2018
Apr. 30, 2019
Apr. 30, 2018
Research and Development Expense [Member]        
Non-cash share-based compensation expenses $ 655,066 $ 155,769 $ 2,228,845 $ 195,826
Selling, General and Administrative Expenses [Member]        
Non-cash share-based compensation expenses $ 666,384 $ 175,941 $ 1,842,769 $ 402,857